Cure for certain cancers is ‘realistic’ goal in next decade, pharma lead says

A cure for cancer could beryllium connected nan sky successful nan adjacent decade, according to experts.

During nan WSJ Leadership Institute CEO Summit successful London past week, Johnson & Johnson Chairman and CEO Joaquin Duato reflected connected nan pharmaceutical company’s projections connected nan early of crab treatment.

In nan adjacent 10 years, nan extremity is to "try to destruct cancer," Duato shared.

NEW CANCER VACCINE DELIVERS STUNNING RESULT AGAINST ONE OF THE DEADLIEST SKIN CANCERS

"That’s a precocious goal, and we are already making important advancement successful certain cancers," he said.

Duato utilized aggregate myeloma arsenic an example, noting that nan life expectancy is presently 10 years, erstwhile it was antecedently "only azygous years."

Joaquin Duato, president and CEO of Johnson and Johnson, speaks astatine nan Punchbowl News Conference astatine Union Station connected March 10, 2026, successful Washington, DC. (Heather Diehl/Getty Images)

"We person treatments now that utilize your ain immune strategy to attack nan cancer," he said astatine nan summit. "For patients who were already going into hospice, truthful they didn’t person immoderate different alternative, they are [at] much than 5 years, pinch a azygous administration, successful remission. That [is] spectacular."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"When patients spot that, they cannot judge that because they person been coming to nan infirmary each week [for] a decade, having aggregate therapies."

The extremity is to "try to destruct cancer" successful nan adjacent 10 years, nan pharmaceutical executive said. (iStock)

According to Duato, Johnson & Johnson is moving to understand nan biology of crab growth and to formulate caller technologies to reside it.

"It’s realistic to judge that we are going to cure definite cancers, and immoderate others we’re going to move into chronic diseases," he predicted.

CLICK HERE FOR MORE HEALTH STORIES

"Cancer is an important point – I cannot deliberation astir anybody who has not been touched by cancer," he went on. "But location are galore different opportunities for america to really advance science, to reside very important societal problems."

Duato called retired dementia arsenic different "important problem" successful request of a solution.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

He predicted that life expectancy, which has risen steadily complete nan past century, will proceed to summation arsenic longevity technologies and solutions advance, improving value of life on nan way.

Duato commented that J&J has been optimistic astir nan domiciled artificial intelligence will play successful nan early of healthcare, calling it a "force multiplier."

Biomarkers and AI tin thief pinch nan earlier test of cancer, arsenic good arsenic a much precocious and personalized attack to surgery, a expert noted. (iStock)

Fox News elder aesculapian expert Dr. Marc Siegel agreed pinch Duato's outlook connected nan early of crab care, noting that definite cancers will move into chronic diseases while others will find outright cures.

"Advances [will be] based connected nan usage of AI to thief guideline targeted treatments pinch expanding knowledge of crab mutations and really to target them," he predicted, speaking to Fox News Digital.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Siegel added that biomarkers and AI tin thief pinch earlier diagnoses, arsenic good arsenic a much precocious and personalized approach to surgery.

J&J precocious acquired Firefly Bio, a biotech patient that produces narcotics that participate crab cells to "target definite proteins that incorporate difficult to dainty cistron mutations," nan expert added.